Copyright
©The Author(s) 2025.
World J Methodol. Mar 20, 2025; 15(1): 94833
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.94833
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.94833
Challenge | Ethical dilemma | Proposed solution |
Reporting of negative outcomes | Balancing the ethical need for transparency with potential reputational or financial consequences for authors and sponsors | Implement policies for mandatory reporting of all outcomes, positive and negative |
Commercial interests | Managing conflicts of interest that may influence the reporting and perception of off-label and experimental treatments | Strict disclosure requirements and independent review to mitigate the impact of commercial interests |
Balancing innovation with caution | Navigating between the advancement of medical science and ensuring patient safety in the face of uncertain treatment outcomes | Development of comprehensive guidelines that prioritize rigorous scientific evaluation and patient safety |
- Citation: Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S. Navigating the ethical terrain: Off-label and experimental treatments in medical case reports. World J Methodol 2025; 15(1): 94833
- URL: https://www.wjgnet.com/2222-0682/full/v15/i1/94833.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i1.94833